Nurse prescriber Charlotte Guest discusses how she treated a case of rosacea using a novel laser device, the QuadroStarPRO YELLOW from Asclepion Laser Technologies.
The frequency at which rosacea occurs in the general public is unclear and often overlooked, but a recent systematic review and meta-analysis estimated a global prevalence of 5.46% of the adult population is affected.1,2 Multiple topical and oral agents have been prescribed over the years for the treatment of rosacea.3,4,5
Furthermore, licensed light-based procedures have also been used which includes pulsed dye lasers (585–595 nm), intense pulsed light (IPL, 500–1200 nm), APTD (577 and 585 nm), krypton (568 nm), potassium titanyl phosphate (KTP, 532nm) and ND:YAG (532 and 1064 nm) lasers.5-8
However, the novel FDA[1]cleared QuadroStarPRO YELLOW with a 577 nm wavelength widens treatment options for practitioners when treating rosacea, superficial red vessels and benign pigmentated lesions…
